• PDB52 Adheren A Real World Retrospective Database Study Among Type 2 Diabetes Patients Treated With Liraglutide or Exenatide

    Nov 1, 2012, 00:00

  • PRM88 Translation and Validation of Osteoporosis Health Belief Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PRM164 Ensuring the Value of a Medical Device Innovation Prior to Market Launch

    Nov 1, 2012, 00:00

  • PHS73 Willingness of the Health Care Consumers to Pay for Health Care Services – Results from a Contingnet Valuation Study

    Nov 1, 2012, 00:00

  • PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 Participants

    Nov 1, 2012, 00:00

  • PIN35 Cost of Antimicrobial Prescribing Using a Large Pharmacy Database in South Africa

    Nov 1, 2012, 00:00

  • PCN125 Cost of Presenteeism Due to Cancer in Poland

    Nov 1, 2012, 00:00

  • PMD20 Budget Impact of Drug Eluting Balloons for Intermittent Claudication From Superficial Femoral Artery Disease in the United States Health Care System

    Nov 1, 2012, 00:00

  • PDB20 Safety of Preoperative Vitamin D Replacement in Mild Primary Hyperparathyroidism With Vitamin D Deficiency- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP83 The OTC Policy in Eyrope and Greece

    Nov 1, 2012, 00:00

  • PMS62 Nominal Group Technique to Select Attributes for Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PHP193 Paediatric Use Marketing Authorisation (PUMA)- The Challenges of Cost-Effectiveness Modelling Where Limited Clinical Trial Information is Available

    Nov 1, 2012, 00:00

  • PCN13 Analysis of the Impact of Prophylactic Vaccination Against Human Papillomavirus Infection Using a Dynamic-Modelling Approach

    Nov 1, 2012, 00:00

  • PIN76 Health Related Quality of Life of HIV Infected Intravenous Drug Users

    Nov 1, 2012, 00:00

  • PRM28 A Refined Comorbidity Index for the Studies of Health Related Quality of Life

    Nov 1, 2012, 00:00

  • UT1 The Calculation of Quality of Life Utilities for Acute Leukemia- A Comparison Between EQ5D-5L and QlQ-C30

    Nov 1, 2012, 00:00

  • PRS41 Characteristics and Determinants of Palivizumab Use in the Netherlands

    Nov 1, 2012, 00:00

  • PGI1 The Effectiveness and Tolerability of Combined Treatment With Peginterferon Alpha-2a or Alpha-2b and Ribavirin in the Treatment of Patients With Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registry in Japan

    Nov 1, 2012, 00:00

  • PCV56 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at LDL Cholesterol Treatment Goal in Brazil

    Nov 1, 2012, 00:00

  • PCV35 Correlation Among Pre-Operative Conditions, Waiting Time and Outcome of Elective Patients in Cabg Waiting List in Harapan Kita Hospital 2011

    Nov 1, 2012, 00:00

  • PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings- Are More Advanced Techniques Really Performing Better?

    Nov 1, 2012, 00:00

  • PIH31 Intentional and Unintentional Non-Adherence Differ Across Prevalent Conditions in a Russian Patient Population

    Nov 1, 2012, 00:00

  • PHP86 Outcomes and Factors Associated with Hospital Mortality in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Grafting; Where Do We Stand?

    Nov 1, 2012, 00:00

  • PRS2 Meta-Analysis of the Effects of Theophylline on Kidney Function in Neonates With Perinatal Asphyxia

    Nov 1, 2012, 00:00

  • PHP49 Irrational Use of Antibiotics in Children by Medical Prescribers

    Nov 1, 2012, 00:00

  • PHS57 Comparing Predictors of Self-Reported Adherence to Mammography Screening Guidelines in Appalachian Women Who Utilize Mobile and Stationary Facilities

    Nov 1, 2012, 00:00

  • PIN46 Pharmacoeconomic Evaluation of the Introduction of Universal Varicella Vaccination in Italy

    Nov 1, 2012, 00:00

  • PMH20 Metabolic Consequences and Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder

    Nov 1, 2012, 00:00

  • PCV12 Determinants of Exposure to Potential Interactions Between Antiplatelet Drugs, Anticoagulants, Digoxin and Common Chinese Medications in Taiwan

    Nov 1, 2012, 00:00

  • PRM63 Long-Term Burden of Asthma in Children With Allergic Rhinitis/ Conjunctivitis

    Nov 1, 2012, 00:00

  • PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada

    Nov 1, 2012, 00:00

  • PRM47 Cost-Effectiveness Uncertainty Analysis Methods- A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information

    Nov 1, 2012, 00:00

  • PMS53 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Kyphoplasty/Vertebroplasty Patients

    Nov 1, 2012, 00:00

  • PSY16 Effect of the Anti-Tumor Necrosis Factor Adalimumab on Work Productivity in Patients With Chronic Immune-Mediated Inflammatory Diseases- Literature Review

    Nov 1, 2012, 00:00

  • PCN72 Modeling the Survival Loss in Patients With Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP) Switched from Imatinib Mesylate to a Generic Copy

    Nov 1, 2012, 00:00

  • PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5D

    Nov 1, 2012, 00:00

  • PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PHP56 Horizontal Equity in Primary Health Care Services in Times of Economic Crisis in Gree Ex Ante and Ex Post Findings

    Nov 1, 2012, 00:00

  • PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the Netherlands

    Nov 1, 2012, 00:00

  • PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium- Decrease of Rotavirus-Positive Stool Samples in Hospitalised Children

    Nov 1, 2012, 00:00

  • PND55 Multiple Sclerosis Impact Scale (MSIS-29)- Its Validity and Responsiveness in Clinical Trial-Based Subjects

    Nov 1, 2012, 00:00

  • PHP40 AMNOG- Pricing Reforms in Action

    Nov 1, 2012, 00:00

  • PRM43 Roles and Selection of Comparative Treatment(s) in the Assessment of New Drug Reimbursement and Pricing Application to Taiwan National Health Insurance (NHI)

    Nov 1, 2012, 00:00

  • PHP9 Drug Pricing in Bosnia and Herzegovina

    Nov 1, 2012, 00:00

  • PCN100 Cost Utility Analysis of Bortezomib in a Biomarker Positive Subgroup of Relapsed and Refractory Folicular Lymphoma

    Nov 1, 2012, 00:00

  • PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes - A Population Based Study

    Nov 1, 2012, 00:00

  • PRM106 Examination of Preferences Elicited From the General Public- Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of Psoriasis

    Nov 1, 2012, 00:00

  • PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in Fran A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PHP124 Comparison of HTA Dossier Requirements Across Europe

    Nov 1, 2012, 00:00

  • PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease- Differences Between Modalities of Renal Replacement Therapy

    Nov 1, 2012, 00:00

  • PMH12 Are Disease Related Costs of Care for Major Depression in Germany Overestimated? – Using Claims Data to Assess the Influence of Disease Severity and Comorbidity

    Nov 1, 2012, 00:00

  • PND59 Cross-Cultural Validation of the Huntington'S Disease Quality of Life Battery for Carers in France and Italy

    Nov 1, 2012, 00:00

  • PIH15 Prescribing Cost of Enzymes Over a Two-Year Period Using a Medical Insurance Claims Database

    Nov 1, 2012, 00:00

  • PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening Preferences

    Nov 1, 2012, 00:00

  • PCN11 Decreased Risk of Prostate Cancer in Type 2 Diabetes Patients- A Meta-Analysis of Cohort Studies

    Nov 1, 2012, 00:00

  • PHP195 Adoption of New Technologies in Twenty Established and Emerging Markets

    Nov 1, 2012, 00:00

  • PHP158 Cross-Funtional Challenges in the Preparation of a Benefit Dossier

    Nov 1, 2012, 00:00

  • PHP43 The High Cost of Treating Cancer- Do Manufacturer Pricing Policies Take Affordability Into Account?

    Nov 1, 2012, 00:00

  • PHS33 Cost Analysis of Dialysis Practice in Turkey

    Nov 1, 2012, 00:00

  • PMS6 Disease Burden of Rheumatoid Arthritis in Mainland China- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PND20 12-Month Cost of Illness Study of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PHP104 Hypertension Control and Doctors' Knowledge, Attitude and Practices on Malaysian Clinical Practice Guidelines on Management of Hypertension (CPG 2008) at a Tertiary Hospital

    Nov 1, 2012, 00:00

  • PIH50 Trends in Post-Marketing Commitments Related to Pregnancy and Lactation

    Nov 1, 2012, 00:00

  • PCN47 Cost-of-Illness of Common Cancer Types - Results of a Health Insurance Claims Data Analysis

    Nov 1, 2012, 00:00

  • PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012- Slowing Down?

    Nov 1, 2012, 00:00

  • PCN19 Medical Management of Metastatic Renal Cell Carcinoma, Retrospective Analysis of Real World Data Settings

    Nov 1, 2012, 00:00

  • PDB47 Effects of Patient-Reported Non-Severe Hypoglycaemia on Health Care Resource Use and Work-Time Loss in Seven European Countries

    Nov 1, 2012, 00:00

  • PSS21 Evaluation of Health Utility in Patients With Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PCN146 Trends in Computed Tomography Use in Canada- Low-Dose Ionizing Radiation and the Potential Related Cancer Risk

    Nov 1, 2012, 00:00

  • PND64 Quality of Life and Productivity Loss in Patients With Hereditary Angioedema (HAE) in Sweden; Results From a Retrospective Patient Registry Survey Implemented by Sweha-Reg (a Population Based Census of HAE in Sweden)

    Nov 1, 2012, 00:00

  • PCN129 Emerging Market Access Trends- Pricing and Coverage of Targeted Cancer Therapies in Russia (2011-2012)

    Nov 1, 2012, 00:00

  • PRS12 Clinical COPD Questionnaire (CCQ)- Is There a Need to Develop a Specific English Version for the Philippines and India?

    Nov 1, 2012, 00:00

  • PHP104 A Correspondence Analysis of the Patient's Perspective on Shared Decision Making at the Family-Physician Unit

    Nov 1, 2012, 00:00

  • PCN65 Cost-Effectiveness Analysis of Introducing HPV Vaccines in Colombian Women

    Nov 1, 2012, 00:00

  • PIN9 A Multi-Center, Retrospective, Chart Review Study to Compare Direct Health Care Costs of Treatment Experienced Patients With HV/AIDS Before and After Triple Class Failure in Thailand

    Nov 1, 2012, 00:00

  • PCN95 Pharmacoeconomic Analysis of Direct Medical Costs Associated With the Treatment of Advanced Esophago-Gastric Cancer Therapy With Xeloda or 5-Fluorouracil (5-FU) Regimens- Implications for Health Care Utilisation in Australia

    Nov 1, 2012, 00:00

  • PHP72 New Pricing Policies After Initiation of the Health Transformation Programme in Turkey

    Nov 1, 2012, 00:00

  • PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

    Nov 1, 2012, 00:00

  • PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in Germany

    Nov 1, 2012, 00:00

  • PCN44 Cost Comparison Analysis of Antibody Therapies in the Metastatic Colorectal Carcinoma

    Nov 1, 2012, 00:00

  • PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

    Nov 1, 2012, 00:00

  • PGI1 Acne Drug Therapy and the Development of Comorbid Inflammatory Bowel Disease in the United States

    Nov 1, 2012, 00:00

  • PDB69 Diffusion of New Technologies Post Reimbursement – Monitoring the Use of Liraglutide in Primary Care

    Nov 1, 2012, 00:00

  • PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease Control

    Nov 1, 2012, 00:00

  • PSY13 Pilot Cost Study of Chronic Mieloid Leukemia Therapy

    Nov 1, 2012, 00:00

  • PDB28 Cost of Disease and its Relationship With Diabetic Complications in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM172 The Value of Personalized Medicine- It is More About Unveiling the Performance of the Companion Diagnostic

    Nov 1, 2012, 00:00

  • PCN106 Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Results of a Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PMH57 HTA Landscape of Treatments Available for Alcohol-Related Disorders

    Nov 1, 2012, 00:00

  • PCN135 The Economic Value of Medical Progress, the Case of Cancer in France (1990-2010)

    Nov 1, 2012, 00:00

  • PHP10 The Margin Between Acquisition Costs and Reimbursement Prices of Generic Drugs (yakkasa) in Japan- Current Status and Determinants

    Nov 1, 2012, 00:00

  • PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic Therapy

    Nov 1, 2012, 00:00

  • PRM44 Increasing Life Expectancy- Implications for Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PSY11 Swedish Adaptation of Czech Pharmacoeconomic Comparison of Treatments in Haemophilia Patients With Inhibitors

    Nov 1, 2012, 00:00

  • PHP105 Impact of Clinical Pharmacy Program on Prescription Errors in a Lebanese Institution- A Cost Benefit Analysis

    Nov 1, 2012, 00:00

  • PIN6 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C Treatment

    Nov 1, 2012, 00:00

  • PRS9 Allergies- Distribution and Perception in the German General Population

    Nov 1, 2012, 00:00

  • PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults

    Nov 1, 2012, 00:00

  • PRM127 Measuring Quality of Life in Mental Health- Issues and Challenges

    Nov 1, 2012, 00:00

  • PHP8 A Survey of “Joint Working” Between the Pharmaceutical Industry and the National Health Service in the UK

    Nov 1, 2012, 00:00

  • PMH1 Antagonistic Drug Prescribing- Cholinesterase Inhibitors and Anticholinergics

    Nov 1, 2012, 00:00

  • PCV121 Relationship Between Primary Care Physicians Profile, Self-Perceived Health and Recommendations to Their Patients

    Nov 1, 2012, 00:00

  • PUK20 Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia Patients

    Nov 1, 2012, 00:00

  • PMH56 Most Frequently Diagnosed Mental Health Problems in a German Population

    Nov 1, 2012, 00:00

  • PIN79 Hepatitis C Virus Infection Increases the Risk of Alzheimer'S Diseases

    Nov 1, 2012, 00:00

  • PSS33 Treatment Patterns of Biologic Use in Psoriasis Patients in England

    Nov 1, 2012, 00:00

  • PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong Kong

    Nov 1, 2012, 00:00

  • PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PHS68 An Assessment of Impairment of Productivity Among SLE Patients

    Nov 1, 2012, 00:00

  • PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver Metastases

    Nov 1, 2012, 00:00

  • PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in Boys

    Nov 1, 2012, 00:00

  • PHS6 Diagnosis Rates for Alzheimer's Disease in Taiwan in 2005 by Age Using National Health Insurance Claims Data

    Nov 1, 2012, 00:00

  • PHP134 Biosimilar Pricing- Past, Present and Future

    Nov 1, 2012, 00:00

  • PMD92 Inhaler Use in Five European Countries- Analysis of Sales Data From Q4 2005 to Q4 2011

    Nov 1, 2012, 00:00

  • PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical Companies

    Nov 1, 2012, 00:00

  • PCN141 Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients with Chemotherapy Induced Febrile Neutropenia (FN) in the Netherlands

    Nov 1, 2012, 00:00

  • PHP40 Equity in Pharmaceutical Pricing and Reimbursement- Crossing the Income Divide in Asia Pacific

    Nov 1, 2012, 00:00

  • PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiG

    Nov 1, 2012, 00:00

  • PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek Population

    Nov 1, 2012, 00:00

  • PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China- A Cross-Sectional Study

    Nov 1, 2012, 00:00

  • PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults

    Nov 1, 2012, 00:00

  • PCN98 Health Outcome Gains and Costs Offset Associated With Everolimus for the Treatment of Hormone-Receptor–Positive (HR+) HER2-Negative (HER2–) Advanced Breast Cancer (ABC)

    Nov 1, 2012, 00:00

  • PCV36 Increasing Costs for German Social Health Insurance (SHI) Funds by Abandonment of Pentaerithrityltetranitrat (PETN) for Patients With Coronary Heart Disease (CHD)? – A Cost Analysis Based on Sick Fund Data

    Nov 1, 2012, 00:00

  • PHP91 Using Observational Comparative Effectiveness Studies to Inform Decision Making- The Need for a Two-Phase Approach to Assessing Quality and Appropriateness

    Nov 1, 2012, 00:00

  • CL2 Usefulness of Days Lost Due to Disability As a New Method in Measuring Burden of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PCV75 Complementing Data for Rare Diseases - Comparing Data From National Registries to a European Chart Abstraction Study for Patients With Chronic Thromboembolic Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PND42 Cost-Effectiveness of Onabotulinumtoxin-a for the Prophylaxis of Chronic Migraine

    Nov 1, 2012, 00:00

  • PCN123 A Conjoint Analysis of Willingness to Pay to Avoid Metastatic Breast Cancer Side Effects

    Nov 1, 2012, 00:00

  • PRM42 Multiple Criteria Decision Analysis for Health Technology Assessment

    Nov 1, 2012, 00:00

  • EX4 Recent Trends in Community Pharmacy Payment of National Health Insurance in South Korea

    Nov 1, 2012, 00:00

  • PMD10 Analysis of Costs of Complications for Stroke Prevention in Atrial Fibrillation Patients, Comparing Dose-Adjusted Warfarin to Left Atrial Appendage Closure

    Nov 1, 2012, 00:00

  • PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients- An Exploratory Economic Evaluation of Personalized Medicine

    Nov 1, 2012, 00:00

  • PHS96 The Impact of the Implementation of NICE Guidance on Venous Thromboembolism Risk Assessment and Patient Safety Across Four Hospitals in England

    Nov 1, 2012, 00:00

  • PHS37 Cost Minimization Analysis in the Treatment of Community Acquired Pneumonia in Ukraine

    Nov 1, 2012, 00:00

  • PUK22 Evaluating the Minimum Renal Allograft Survival Time Required for Transplantation to Remain Cost Saving in the UK

    Nov 1, 2012, 00:00

  • PDB56 Development and Validation of Patient Reported Endpoints for T2DM

    Nov 1, 2012, 00:00

  • PDB53 Preliminary Results of a Multicenter Observational Study of Treatment Compliance With Free-Combination Versus Fixed Combination Treatment in Type II Diabetes Mellitus Patients in Greece (Less Study)

    Nov 1, 2012, 00:00

  • PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic Review

    Nov 1, 2012, 00:00

  • PHP105 Guideline Implementation in Long Term Asthma Management- An Audit Using a Medication Assesssment Tool in Selayang Hospital

    Nov 1, 2012, 00:00

  • PCV99 EQ-5D Utilities in Patients Hospitalised With Heart Failure in Canary Islands

    Nov 1, 2012, 00:00

  • CL3 Anticoagulation Control of a Pharmacist Managed Anticoagulation Clinic in a National Referral Centre in Malaysia

    Nov 1, 2012, 00:00

  • PSY9 Medical Cost of Organ Damage Due to Systemic Lupus Erythematosus

    Nov 1, 2012, 00:00

  • PMS60 The Time Horizon Matters- Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility Elicitation

    Nov 1, 2012, 00:00

  • PMD8 One Year Evaluation of Effectiveness and Device Complication Outcomes in the Helping Evaluate Reduction in Obesity (HERO) Study

    Nov 1, 2012, 00:00

  • PRS24 Cost-Effectiveness of Varenicline Compared With Bupropion and NRT (Nicorette) for Smoking Cessation in Austria

    Nov 1, 2012, 00:00

  • PND10 Faster Cognitive Decline is Associated With Decreasing Survival in Patients With Alzheimer'S Disease

    Nov 1, 2012, 00:00

  • PHP112 Usage of Self-Monitoring of Blood Glucose (SMBG) by Diabetes Therapy Type in Larger Cities in China

    Nov 1, 2012, 00:00

  • PRM23 Discriminative Properties of SF36v2 Health Survey in General Population of Penang State (Malaysia) Using Norm Based Scoring Algorithms

    Nov 1, 2012, 00:00

  • PRM174 The Need to Conduct Future Research on the Benefit of the Prostate Specific Antigen Screening Test Using the Value of Information Framework

    Nov 1, 2012, 00:00

  • PCN25 Utility of Advanced Non-Small Cell Lung Cancer Patients in Thailand- Preliminary Study

    Nov 1, 2012, 00:00

  • PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies- Problems and Solutions

    Nov 1, 2012, 00:00

  • PSS34 Impact of Specialty on Patient-Physician Interaction and Treatment Patterns- An on-Line Study of Eczema Patients

    Nov 1, 2012, 00:00

  • PMH5 Does Participation in a Weight Control Program Also Improve Clinical and Functional Outcomes for Chinese Patients with Schizophrenia Treated with Olanzapine?

    Nov 1, 2012, 00:00

  • PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement Policy

    Nov 1, 2012, 00:00

  • PRM77 Mapping the Meanings of Words Patients Use to Describe Their Pain

    Nov 1, 2012, 00:00

  • PHP76 Use of Estimates in the Economic Model of the Impact of New Health Coverage in Private Brazilian Market

    Nov 1, 2012, 00:00

  • PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic

    Nov 1, 2012, 00:00

  • PCN24 Treatment and Response Patterns in Chronic Myeloid Leukemia- Evidence from a Retrospective Study in Canada, Australia, and South Korea

    Nov 1, 2012, 00:00

  • PHP121 Drug Reimbursement Maintenan A French Challenge in 2011

    Nov 1, 2012, 00:00

  • PHS25 Direct Medical Costs of Medical Care of Gastrointestinal Bleeding in Mexico

    Nov 1, 2012, 00:00

  • PIN82 The Macro-Economic Impact of Reducing Malaria- An Application of a Dynamic General Equilibrium Modelling to Ghana

    Nov 1, 2012, 00:00

  • PHP39 Prescription Filling on Outpatient Health Care Departments- An Indonesia Family Life Survey (IFLS) Year 2007 – 2008 Based Study

    Nov 1, 2012, 00:00

  • CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

    Nov 1, 2012, 00:00

  • PSU23 Women's Preferences for Breast Reconstruction- A Study Using a Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques

    Nov 1, 2012, 00:00

  • PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PDB16 Geographic Variation Trends in Diabetes Mellitus Prevalence in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PSS22 Impact of Patient Satisfaction on Health Related Quality of Life, in Psoriasis Patients Receiving Traditional Systemic Therapy

    Nov 1, 2012, 00:00

  • HT2 Cost-Effectiveness Analysis of Bone Mineral Density Screening Tools

    Nov 1, 2012, 00:00

  • PMH10 Cost-Effectiveness of Antidepressant Based on Discrete Event Simulation Modeling in Treatment of Major Depressive Episodes- A Comparison of Agomelatine Versus Escitalopram-Venlafaxine

    Nov 1, 2012, 00:00

  • PCV74 Economic Evaluation of Cardio Incode, A Genetic Platform for the Assessment of Ischemic Heart Disease Risk

    Nov 1, 2012, 00:00

  • PRM18 Modeling Long-Term Health Outcomes in Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PHP99 Identifying Major Operational Causes and Potential Remedies for Emergency Department Over-Crowding-Crowding

    Nov 1, 2012, 00:00

  • PND35 Buccolam® (Licensed Oromucosal Midazolam) Versus Rectal Diazepam for Acute Epileptic Seizures- Italian Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM145 A Maximum Likelihood Simulation Technique for Estimating Adverse Event Rates From Published Trials

    Nov 1, 2012, 00:00

  • PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-Review

    Nov 1, 2012, 00:00

  • PMS75 Real-World Utilization Patterns of Rheumatoid Arthritis Medications in the United States- Anti-TNF Monotherapy and Adherence With Non-Biologic DMARDs in Combination with Anti-TNF Therapy

    Nov 1, 2012, 00:00

  • PND12 A Cost-Effectiveness Analysis of Self-Administrated Injection of Sumatriptan Succinate for Patients With Severe Migraine in Japan Setting

    Nov 1, 2012, 00:00

  • UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder- Response to Stimulant Treatment

    Nov 1, 2012, 00:00

  • PHS82 Determinants of Health Service Utilization in Urban Pakistan

    Nov 1, 2012, 00:00

  • PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in Sweden

    Nov 1, 2012, 00:00

  • PCN5 Cabazitaxel Plus Corticosteroids in Comparison to Corticosteroids Alone for the Treatment of Metastatic Hormone Refractory / Castration-Resistant Prostate Cancer (mHRPC)

    Nov 1, 2012, 00:00

  • PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PHP110 Gaining Reimbursement of Orphan Products in Europe- Challenges Due to Wide Variations in Evidence Requirements and Processes

    Nov 1, 2012, 00:00

  • PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip Replacement

    Nov 1, 2012, 00:00

  • PHP98 The Industry Survey Results Regarding Korea PE Guideline Revision

    Nov 1, 2012, 00:00

  • PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000

    Nov 1, 2012, 00:00

  • PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PRM118 Methodology for Neuropsychological Assessment Wordlist Adaptation

    Nov 1, 2012, 00:00

  • PMH55 Payer Value in Alternative Treatment Formulations- Access to New Medicines in Schizophrenia

    Nov 1, 2012, 00:00

  • PMH53 Preventing Alzheimer Disease- Is There a Place for Cost-Effective Interventions? Dynamic Modeling Applied to a Pan European Analysis

    Nov 1, 2012, 00:00

  • PDB68 Physician Beliefs About Insulin Pens Versus Vials, Therapy Choice Factors, and Patient Characteristics Among Elderly Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PCN62 Cost Impact Modeling of Targeted Molecular Profiling in the Treatment of Colon Cancer

    Nov 1, 2012, 00:00

  • PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnaire

    Nov 1, 2012, 00:00

  • PHP168 Calculated Forecast for Technical Obsolescence in Computerised Tomography Equipment

    Nov 1, 2012, 00:00

  • PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk Management

    Nov 1, 2012, 00:00

  • PRS33 Factors Affecting Adherence to COPD Therapy in 5EU

    Nov 1, 2012, 00:00

  • CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention

    Nov 1, 2012, 00:00

  • PRM136 A Utility Single Score Derived From Short Form-36 and Health Assessment Questionnaire in Patients With Antiphospholipid Antibody Syndrome- A Methodolodical Proposal

    Nov 1, 2012, 00:00

  • PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European Guidelines

    Nov 1, 2012, 00:00

  • PMD80 Preferences for a New Imaging Technique to Detect Breast Cancer

    Nov 1, 2012, 00:00

  • PRM31 Chinese Valuation of EQ-5D Health States With the Time Trade-Off Method

    Nov 1, 2012, 00:00

  • PGI17 Cost-Effectiveness of Telaprevir With Peginterferon and Ribavirin for Treatment-Naive Patients Chronically Infected With HCV of Genotype 1 in Japan

    Nov 1, 2012, 00:00

  • PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoV ...

    Nov 1, 2012, 00:00

  • PDB7 Clinical and Resource Utilization Outcomes- Elderly Type 2 Diabetes Patients Initiating Insulin Pens Versus Vials

    Nov 1, 2012, 00:00

  • PCN8 The Association Between Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk in Taiwan- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PIN87 Lengt of Stay and Costs for Patients With Recurrent Clostridium Difficile Infections in Sweden

    Nov 1, 2012, 00:00

  • PIN49 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Elderly Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

    Nov 1, 2012, 00:00

  • PDB74 Effective Health Care Budget Planning for Innovative Drugs in Diabetes Treatment in Turkey; From the Perspective of the Social Security Institution (SSI)

    Nov 1, 2012, 00:00

  • PCN49 Economic Burden of Melanoma in Russia

    Nov 1, 2012, 00:00

  • PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the Netherlands

    Nov 1, 2012, 00:00

  • PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada

    Nov 1, 2012, 00:00

  • PMH11 Costs of Children With Attention Deficit Hyperactivity Disorder (ADHD) Being Compliant or Non-Compliant to Pharmacological Treatment- Results From a Dutch Observational Study

    Nov 1, 2012, 00:00

  • PRS10 An Analysis of Reported Pneumonia Deaths in Malaysia

    Nov 1, 2012, 00:00

  • PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South Africa

    Nov 1, 2012, 00:00

  • PSS7 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study)- 6-Month Findings

    Nov 1, 2012, 00:00

  • PSY6 The Prevalence and Treatment Status of Hemophilia in Mainland China- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications- Results From a Novel Patient Registry

    Nov 1, 2012, 00:00

  • PCN10 Risk of Breast Cancer and Statins- A Population-Based Nested Case-Control Study in Chinese Population

    Nov 1, 2012, 00:00

  • PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PCV46 The Pharmacoecomomic Analysis of Iloprost in Critical Limb Ischemia

    Nov 1, 2012, 00:00

  • PIH4 Immunization Status and Families' Factors in Iraq

    Nov 1, 2012, 00:00

  • PND32 Economic Evaluation of Natalizumab for the Treatment of Multiple Sclerosis in Mexico

    Nov 1, 2012, 00:00

  • PHP132 Time to Market Access for Innovative Drugs in the UK, France, and Belgium

    Nov 1, 2012, 00:00

  • PHP17 Role of Subgroup Analyses for Technology Assessment and Coverage Decisions

    Nov 1, 2012, 00:00

  • PCV77 Analysis of Hospital-Specific Drg Payments for Stroke According to United States Medicare Perspective

    Nov 1, 2012, 00:00

  • PHP95 Efficiency of Greek Hospitals- Best Practices of Three Top-Performing Hospitals

    Nov 1, 2012, 00:00

  • PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PDB38 Cost-Effectiveness of Insulin Detemir in People With Type 2 Diabetes in Romania

    Nov 1, 2012, 00:00

  • PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development Process

    Nov 1, 2012, 00:00

  • PIH7 Immunization Providers' Cost and Vaccination Cost in Iraq

    Nov 1, 2012, 00:00

  • PHP53 Comparative Evaluation of Drug Information Sources Used by Doctors

    Nov 1, 2012, 00:00

  • PHS48 Cost-Effectiveness Analysis of Tolvaptan for Hyponatreamia in South Korea

    Nov 1, 2012, 00:00

  • PRM55 Third Party Model Validity- A Review and Survey of Face and Internal Validity of Health Economic Models

    Nov 1, 2012, 00:00

  • PMH58 The Impact of ADHD Medication Attributes on Physician Prescribing Behavior in the EU- Results From Chart-Reviewed Data

    Nov 1, 2012, 00:00

  • PMD62 Cost-Effectiveness in Diagnostic Tests- Comparison of the IBD Pre-Endoscopic Screening F-Calprotectin Test Versus Serologic Markers in Selected European Markets

    Nov 1, 2012, 00:00

  • PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ)

    Nov 1, 2012, 00:00

  • PHP197 Opportunities and Limitations of Sustainability Indices in Satisfying the Needs of Health Technology Purchasers Seeking Objective and Unbiased Indicators of Environmental and Societal Impacts

    Nov 1, 2012, 00:00

  • PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Confirm Study

    Nov 1, 2012, 00:00

  • PDB16 Prospective and Retrospective Safety Review of Pioglitazone in a Medical Center

    Nov 1, 2012, 00:00

  • PMH47 Willingness to Pay for Key Attributes of the new Long Acting Injectable Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • PMS3 Improvements in Patient-Reported Pain and Global Disease Activity in Rheumatoid Arthritis Patients After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PRM20 Empirical Analysis Shows Reduced Cost Data Collection May Be an Efficient Method in Economic Clinicl Trials

    Nov 1, 2012, 00:00

  • PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder- Patient Characteristics and 1-Year Costs

    Nov 1, 2012, 00:00

  • PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada)

    Nov 1, 2012, 00:00

  • PHP151 The Influence of Patient Compliance Arguments in Nice Technology Appraisals

    Nov 1, 2012, 00:00

  • PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal Infections

    Nov 1, 2012, 00:00

  • PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia- An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

    Nov 1, 2012, 00:00

  • PCN48 The Cost of Treating Penile Cancer in English Hospitals- Preliminary Results Using the Hospital Episodes Statistics (HES) Database

    Nov 1, 2012, 00:00

  • PRM13 Overview of PRO Instruments from the PROQOLID Database for Use in Taiwan

    Nov 1, 2012, 00:00

  • PRM159 Sensitivity Analysis Versus Uncertainty Analysis in Health Economic Decision Making

    Nov 1, 2012, 00:00

  • PHS41 Cost Effectiveness Analysis of Two HIV Counseling and Testing Strategies in Kayunga District (Uganda)

    Nov 1, 2012, 00:00

  • PRM99 Translation and Validation of Osteoporosis Self-Efficacy Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PRM32 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PSS4 Acne and Lifestyle- Results of a Survey on a Representative Sample of the French Population

    Nov 1, 2012, 00:00

  • PHP143 Exploratory Test of Stakeholder Theory in the Implementation Process of It-Innovations in Hospital Care

    Nov 1, 2012, 00:00

  • PIN31 Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia- 2011

    Nov 1, 2012, 00:00

  • PIN23 Economic Analysis of Atazanavir as 1st Line Treatment for VIH Patients, on Stable and Sever Health State

    Nov 1, 2012, 00:00

  • PIH49 Population Access to Rotavirus Vaccination in Developped Countries- Lessons Learned from Current Experience and Potential Implications for the Future

    Nov 1, 2012, 00:00

  • PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy

    Nov 1, 2012, 00:00

  • PND16 Cost-Effectiveness Analysis of Lacosamide as Adjunctive Therapy in Adults With Partial-Onset Seizures in Mexico

    Nov 1, 2012, 00:00

  • PHP114 Failure for Cost-Sharing Schemes to Take Off in India- What Can Be the Access Solution?

    Nov 1, 2012, 00:00

  • PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in Portugal

    Nov 1, 2012, 00:00

  • PCV39 Cost Assessment of Drugs for Venous Thromboembolism Prevention After Hip or Knee Replacement in Mexican Population

    Nov 1, 2012, 00:00

  • PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over Time

    Nov 1, 2012, 00:00

  • PIN66 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in São Paulo State, Brazil – Public Perspective

    Nov 1, 2012, 00:00

  • PSU22 Health-Related Quality of Life in Prostate Cancer - Comparison of Robot-Assisted and Open Surgery

    Nov 1, 2012, 00:00

  • PGI26 Within-Trial Analysis to Estimate the Economically Justifiable Price of Linaclotide in the Treatment of Irritable Bowel Syndrome With Constipation in the UK

    Nov 1, 2012, 00:00

  • PHP140 Challenges in the Data Collection Regarding Patient Population and Treatment Costs for Non-Drug Interventions Using the Example of Morbus Dupuytren

    Nov 1, 2012, 00:00

  • PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA

    Nov 1, 2012, 00:00

  • PHP116 Equity in the New Rural Cooperative Medical Scheme- Comparison of Benefit Packages for Chronic Disease Outpatients in 32 Counties in China

    Nov 1, 2012, 00:00

  • PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in Taiwan

    Nov 1, 2012, 00:00

  • PIN14 Cost of Treatment for Patient With HIV AIDS in Hospital of East Java, Indonesia

    Nov 1, 2012, 00:00

  • PSY1 Burdens of Psoriasis in the Asia Pacific Region- A Literature Review

    Nov 1, 2012, 00:00

  • PCV9 Meta-Analysis of the Efficacy and Safety of Stevioside (from Stevia Rebaudiana Bertoni) in Blood Pressure Control in Patients With Hypertension

    Nov 1, 2012, 00:00

  • PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling Methods

    Nov 1, 2012, 00:00

  • PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community Setup

    Nov 1, 2012, 00:00

  • PCN74 Cost Effectiveness of Cyclophosphamide in the Adjuvant Treatment of Breast Cancer in Europe- A Multi-Country Study

    Nov 1, 2012, 00:00

  • PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in Asia

    Nov 1, 2012, 00:00

  • PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010

    Nov 1, 2012, 00:00

  • PMS79 Evaluation of Current Health Technology Assessments for Rheumatoid Arthritis – an Insight Into the Key Uncertainties Generated by the Available Evidence

    Nov 1, 2012, 00:00

  • PHP112 Estimating the Probability of a Favorable Assessment of Clinical Benefits for a New Drug in Germany Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PIN11 Economic Burden of Invasive Pneumococcal Diseases in Urban China

    Nov 1, 2012, 00:00

  • PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada

    Nov 1, 2012, 00:00

  • PGI9 Pharmacoeconomic Evaluation of Antyhelicobacter Therapy of Ulcers Duodenum in Ukraine

    Nov 1, 2012, 00:00

  • PGI4 Assessing the Use of a Harmonic Scalpel in Laparoscopic Cholecystectomy- A Systematic Review of the Evidence

    Nov 1, 2012, 00:00

  • PDB13 Bariatric and Metabolic Surgery in China – Efficacy of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PHP196 Stakeholder Involvement in Health Technology Assessment (HTA) of Novel Medical Devices

    Nov 1, 2012, 00:00

  • PRM36 A Chinese Population-Based Study on Preferences for Health States- How Individual Characteristics Matter?

    Nov 1, 2012, 00:00

  • PHS63 Patient Perception of an Oral Systemic Anti-Cancer Therapy Homecare Service

    Nov 1, 2012, 00:00

  • PSY27 A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and II Hereditary Angioedema in the UK Setting

    Nov 1, 2012, 00:00

  • PSU32 A Comparison of Resource Utilization and Medical Charges Among Lumbar Interbody Fusion Surgical Patients With and Without Revision

    Nov 1, 2012, 00:00

  • PRS2 A Retrospective Epidemiologic Review of COPD in Korea

    Nov 1, 2012, 00:00

  • PHP56 The Role of Antineoplastic and Immunomodulating Agents in Works and Recommendations of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011

    Nov 1, 2012, 00:00

  • PHP114 Review of Cost Effectiveness Studies of High Budget Impact Drugs (2007-2012)

    Nov 1, 2012, 00:00

  • PDB18 Population Attributable Risk of Microvascular Events Associated With HbA1C, Blood Pressure or Weight in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PHP200 Effective Demand for a Health Literate Health Care System - Evidence from Irish Survey Data

    Nov 1, 2012, 00:00

  • CL1 A Novel Method for Calculating Prevalence of Multiple Sclerosis in Australia

    Nov 1, 2012, 00:00

  • VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

    Nov 1, 2012, 00:00

  • PMD40 Burden of SSI in Gastrointestinal, Cardiac and Orthopaedic Surgeries in Korea

    Nov 1, 2012, 00:00

  • PCN128 Estimating the Value of Companion Diagnostics- Are the Incentives Right?

    Nov 1, 2012, 00:00

  • PHP123 Importance of Health-Related Quality of Life As an Endpoint in Benefit Assessment According to the German AMNOG

    Nov 1, 2012, 00:00

  • PHS71 Health Related Quality of Life of HIV Patients at a Tertiary Care Hospital in Bangalore

    Nov 1, 2012, 00:00

  • PHP80 Effectiveness of Multidisciplinary Perspective Intervention with Community Involvement in Decreasing Antibiotic Sales in Village Groceries in Thailand

    Nov 1, 2012, 00:00

  • PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in Germany

    Nov 1, 2012, 00:00

  • PHP11 Time Trends and Determinants of Pharmaceutical Expenditure in China in 1990-2009

    Nov 1, 2012, 00:00

  • PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in Russia

    Nov 1, 2012, 00:00

  • PHP28 Systematic Review on Factors Affecting Pharmaceutical Expenditures

    Nov 1, 2012, 00:00

  • PND21 Multiple Sclerosis in Russian Federation- Evaluation of Social and Economical Burden in Real Clinical Practice

    Nov 1, 2012, 00:00

  • PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor Country

    Nov 1, 2012, 00:00

  • PMH24 Cost of Long-Acting Risperidone Injection Versus Long-Acting Paliperidone Palmitate in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PCN126 Can a Population-Based Patient Registry Improve the Feasibility of Outcomes Research in Multiple Myeloma?

    Nov 1, 2012, 00:00

  • PCN84 Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer- An Economic Evaluation in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data

    Nov 1, 2012, 00:00

  • PIN81 Perceptions of Hospital Pharmacists Regarding Effective Anti-Malarial Drug Management in Pakistan. A Qualitative Insight

    Nov 1, 2012, 00:00

  • PCV88 Venous Thromboembolism- A Systematic Literature Review to Identify Multi-Attribute Utility Values for Use in Economic Models

    Nov 1, 2012, 00:00

  • PGI32 New Antiviral Drugs for Hepatitis C in Italy- Will it be a Treasure Hunt?

    Nov 1, 2012, 00:00

  • PRM12 Evidence for Validity of a National Patient-Reported Survey in China- The China National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision Making

    Nov 1, 2012, 00:00

  • PRM142 Use of Body Surface Area As a Determinant of Dose in Cancer Studies

    Nov 1, 2012, 00:00

  • CA2 Applying a Value-Based Price Across Different Disease Areas

    Nov 1, 2012, 00:00

  • PRM36 Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Evolution of Content, Structure, and Functionalities (2002-2012)

    Nov 1, 2012, 00:00

  • PSU35 Epidemiological Modeling of Patient Survival After Heart Transplantation in Germany

    Nov 1, 2012, 00:00

  • PHS45 Cost Effectiveness Analysis of a Specialist Service and Adrenaline Injectors in Anaphylaxis

    Nov 1, 2012, 00:00

  • PHP22 Off-Label Use of Intravenous Non-Steroidal Anti-Inflammatory Drugs-Ketorolac in a Nationally Representative Population

    Nov 1, 2012, 00:00

  • PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or Adalimumab

    Nov 1, 2012, 00:00

  • PND15 Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) Compared to Benzodiazepines for the Treatment of Acute Prolonged Epileptic Seizures in Germany

    Nov 1, 2012, 00:00

  • PIH3 Demographic and Clinical Characteristics of Menopausal Women in the University of Michigan Women's Registry Database

    Nov 1, 2012, 00:00

  • PHP145 Using an Evidence Database of Previous Nice HTA Decisions to Maximise Re-Review Strategy

    Nov 1, 2012, 00:00

  • PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective

    Nov 1, 2012, 00:00

  • PRM146 An Excel Calculator Tool to Perform Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP28 Reasons for Project Discontinuation in the Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PCN153 Application of Real World Data to Inform a Breast Cancer Decision - Analytic Model in Austria and the U.S - Preliminary Outcomes of Data Collection

    Nov 1, 2012, 00:00

  • PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada

    Nov 1, 2012, 00:00

  • PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PCN81 Cost Effectiveness of Pazopanib in Soft Tissue Sarcoma

    Nov 1, 2012, 00:00

  • PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany

    Nov 1, 2012, 00:00

  • PSY7 Societal Burden Associated With Neuropathic Pain in Europe

    Nov 1, 2012, 00:00

  • PMD60 The Costs-Effectiveness of 3M™ CobanTM 2 Layer Compression System (Coban 2) for the Treatment of Lymphoedema in the Netherlands

    Nov 1, 2012, 00:00

  • PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging Markets

    Nov 1, 2012, 00:00

  • PMS44 Cost-Effectiveness of Alendronate Therapy Forcorticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PRM10 Overview of the Prolabels Database Six Years After Its Implementation

    Nov 1, 2012, 00:00

  • PMS66 The Myotonic Dystrophy Type-1 Health Index (MDHI)- An Analysis of its Ability to Differentiate Between Clinically Distinct Populations

    Nov 1, 2012, 00:00

  • PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective Study

    Nov 1, 2012, 00:00

  • PND6 Economic Burden of Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2012, 00:00

  • PRM89 Standardizing the Metric and Increasing the Efficiency of Physical Functioning Outcomes Measurement

    Nov 1, 2012, 00:00

  • PSS8 Non-Interventional Study on the Burden of Illness in Diabetic Macular Edema (DME) in Belgium

    Nov 1, 2012, 00:00

  • PMS56 Impact of Compliance on Fracture Risk for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in Australia

    Nov 1, 2012, 00:00

  • PRS9 Comparison of Knowledge About Tuberculosis among Libyan and Non Libyan TB Patients in North East Libya

    Nov 1, 2012, 00:00

  • PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis

    Nov 1, 2012, 00:00

  • PCN85 Economic Assessment of the Oncotype DX Breast Cancer Assay

    Nov 1, 2012, 00:00

  • PSS7 Cost Effectiveness Analysis of Community Screening for Glaucoma in India

    Nov 1, 2012, 00:00

  • PCV32 A Non-Clinical Randomized Controlled Trial Assessing Impact of Pharmacists Led Intervention Programme for Enhancing Medication Adherence and Health-Related Quality of Life

    Nov 1, 2012, 00:00

  • PSU29 French Survey on the Management of Anemia and Iron Supplementation in Patients in Elective Orthopedic Surgery

    Nov 1, 2012, 00:00

  • PMH54 ADHD Among Adults in Five Western European Countries- An Analysis of National Health and Wellness Survey Data

    Nov 1, 2012, 00:00

  • PDB15 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus Throughout the World- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHP11 Availability and Pricing of Innovative Pharmaceuticals in the Top 5 European Pharmaceutical Markets

    Nov 1, 2012, 00:00

  • PHP117 SMC Decisions- Are They Getting Tougher?

    Nov 1, 2012, 00:00

  • PCN32 Treatment Patterns and Outcomes of Melanoma Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PHP96 Evidence Based Structural Reform in the Provision of Hospital Care- The Case Study of Merging Two Institutions in Hungary

    Nov 1, 2012, 00:00

  • PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in Mexico

    Nov 1, 2012, 00:00

  • PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Algeria

    Nov 1, 2012, 00:00

  • PND33 Cost-Effectiveness Analysis of Genetic Testing of First-Degree Relatives at Risk of Sudden Cardiac Death Due to Gene-Related Cardiopathies in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PMS81 Cost-Effectiveness and Budget Impact of Certolizumab Pegol Against a Mix of Treatments in an Outcomes-Based Risk-Sharing Scheme in Finland

    Nov 1, 2012, 00:00

  • PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM25 Issues and Uncertainties in Combinations of Diagnostic Technologies- A Case Study in Epilepsy Surgery

    Nov 1, 2012, 00:00

  • PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status- An Analysis of United States National Registry Data 2000-2009

    Nov 1, 2012, 00:00

  • PCN7 Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer - A Nationwide Case-Control Study

    Nov 1, 2012, 00:00

  • PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland

    Nov 1, 2012, 00:00

  • PDB32 Outcomes and Perceptions of 4MM Pen Needle Use in Diabetes Patients- Results From a Multi-Center Survey Pilot Study in Hong Kong

    Nov 1, 2012, 00:00

  • PND46 Relationship Between Patient Adherence to Treatment and Spanish Hospital Pharmacy'S Unmet Needs for the Management of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PRS19 Cost-Benefit Analysis of Tiotropium and Salmeterol Treatment Compare to Usual Practice on Sample of Employed Economicaly Active COPD Patients in Ukraine

    Nov 1, 2012, 00:00

  • PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R

    Nov 1, 2012, 00:00

  • PCN32 Quality of Life of Cancer Patients Receiving Capecitabine Monotherapy at Nakhon Pathom Hospital Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PIN77 Elicitation of Health-Related Quality of Life Concepts Associated With Cytomegalovirus in Transplant Recipients

    Nov 1, 2012, 00:00

  • PDB31 The Relationship Between the Cost of Disease and the Presence of Ophthalmic Complications in Type 2 Diabetes Mellitus is Determined via the Concomitant Complications Other Than Ophthalmic Complications

    Nov 1, 2012, 00:00

  • PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy

    Nov 1, 2012, 00:00

  • PIN5 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Community-Acquired Pneumonia (CAP)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in England

    Nov 1, 2012, 00:00

  • PRM39 Survival Curve Convergences and Crossing- A Threat to Validity of Meta-Analysis?

    Nov 1, 2012, 00:00

  • PIH23 A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting

    Nov 1, 2012, 00:00

  • PMS24 Direct and Productivity Costs of Rheumatoid Arthritis in the Slovak Republic – Cost-of-Illness Study

    Nov 1, 2012, 00:00

  • PHS8 Use of Health Care Administrative Databases to Estimate Incidence of Foot Complications in Diabetes Patients

    Nov 1, 2012, 00:00

  • PIN89 European Reference Pricing for Vaccines in Germany- Mechanics and Effects

    Nov 1, 2012, 00:00

  • PHP12 Patented Drug Extension Strategies on Health Care Spending- A Cost-Evaluation Analysis

    Nov 1, 2012, 00:00

  • PRM126 Choice-Based Valuation of the SF-12v1

    Nov 1, 2012, 00:00

  • PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PGI15 Comparison of Knowledge, Attitude and Practice Among Hepatitis-B Patients and Healthy Population Regarding Hepatitis-B

    Nov 1, 2012, 00:00

  • PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple Myeloma

    Nov 1, 2012, 00:00

  • PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 Placebo

    Nov 1, 2012, 00:00

  • PIH3 Pregnancy Outcomes Folowing Exposure to Serotonin Reuptake Inhibitors- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PND72 Access, Uptake and Utilization Management of Multiple Sclerosis Products in the United States

    Nov 1, 2012, 00:00

  • PCV9 Association Between Persistence With Statins and Reduction of Low Density Lipoprotein Cholesterol- Analysis of Real-Life Data from Community Settings

    Nov 1, 2012, 00:00

  • PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125 (current)
  • 126
  • 127
  • 128
  • 129
  • 130
  • »